CASºÅ²éѯ»¯¹¤²úÆ·

ÈÈÃÅËÑË÷»¯Ñ§Æ·×î¶àÖ»ÏÔʾǰ20Ìõ£¬Çëµã»÷¡°ËÑË÷»¯Ñ§Æ·¡±²é¿´ËùÓнá¹û


CASµÇ¼ºÅ ÖÐÎÄÃû Ó¢ÎÄÃû ·Ö×ӽṹʽ ·Ö×Óʽ ÏêÇé ¹©Ó¦ÉÌ
116209-55-3×óÐý±¶ËûÂå¶ûLevoBetaxolol HCL;
LevoBetaxolol HCL;
2-Propanol, 1-[4-[2-(cyclopropylmethoxy)ethyl]phenoxy]-3-[(1-methylethyl)amino]-, Hydrochloride, (2S)-;
2-Propanol, 1-[4-[2-(cyclopropylmethoxy)ethyl]phenoxy]-3-[(1-methylethyl)amino]-, Hydrochloride, (S)-;
AL 1577A;
Betaxon;
LevoBetaxolol Hydrochloride
CAS:116209-55-3·Ö×ӽṹC18H30ClNO3ÏêÇ鹩ӦÉÌ
ÈÈÃÅËѹؼü´Ê:afimoxifene BB003 Ethyl dodecyl ether chapa ¶þ ÒìÇèËáõ¥ C6H9FN4O coffea 1,3-?t???¡¤?¨¬¨ª¨¦ Nocrac Cluster ¼×»ù ÂÈ ±ûÍé tinn Zinc alloy benzoyl benzoate ßÁà¤-1-æf ketoxime Ethyldimethylamine Lich2ch3 EC 321€ EC 111 EC 1119 EC 3217 Methylammonium Chloride ¶þ·úÑǼ׻ù Ë«·ÓA¶þ DL-Leucic Îý CAS NO »Ç°·¼ä à×à¤ÄÆ N-¶¡»ù¶Ô¼×±½»Çõ£°· ¶¡õ¥ cas 4,4-¶þ¼×Ñõ»ùÁª±½ 3,5,7-Èý¼×»ù½ð¸ÕÍé°· N -ÒÒõ£°ëÈéÌÇ°· °±»ù ¹è ÒÒÏ©»ù ±ûͪ»ù ±ûͪ N-[[[2-(Èý¼×Ñõ¹è»ù)ÒÒ»ù]±½»ù]¼×»ù]-1,2-ÒÒ¶þ°· ±½°· ÒÒëæ ±½ ÒÒ°· ¦Å ¹ÈçÞ´¼ c21h21p